Infections and autoimmunity: the multifaceted relationship
Open Access
- 16 December 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 87 (3), 385-395
- https://doi.org/10.1189/jlb.0709517
Abstract
The relationship between infections and autoimmunity as well as the risk of infections due to antirheumatic agents, including corticosteroids, immunosuppressants and biologics, are discussed. Multiple factors are thought to contribute to the development of immune response to self, including differences in genotypes, hormonal milieu, and environmental factors. This review focuses on the pivotal role of infection in the induction of autoimmune disorders. Although the development of autoimmune phenomena linked to infections is a common finding, the onset of autoimmune diseases is a rare event, arising from a combination of genetic susceptibility and environmental factors. There are several mechanisms through which pathogens can initiate or perpetuate autoimmunity. Some of them are antigen-specific, including molecular mimicry, expression of modified, cryptic, or new antigenic determinants, and superantigens. Others are nonspecific and collectively known as “bystander activation.” They include enhanced processing and presentation of self-antigens, immune cell activation, cytokine release, and cell apoptosis/necrosis. Infections may also trigger organ-specific autoimmune diseases, but studies carried out until now have provided conflicting and inconclusive results regarding the role of viral and bacterial agents. Infections and autoimmune diseases have multifaceted and multidirectional relationships. It has been suggested recently that infections cannot only induce or precipitate autoimmune diseases, but they may also protect from autoimmunity or even abrogate an ongoing autoimmune process depending on the interaction between microorganisms and host. Therefore, we should look at microorganisms, not only as causes of infections but also as potential agents able to modulate the immune system. On the other hand, numerous evidences have emerged regarding the higher susceptibility of autoimmune patients to infections, possibly as a result of immunosuppressive therapy and treatment with biologic agents.Keywords
Funding Information
- Italian Medicines Agency (FARM5KJ9P5)
This publication has 100 references indexed in Scilit:
- Infections and autoimmunity – friends or foes?Trends in Immunology, 2009
- CD24 and Siglec-10 Selectively Repress Tissue Damage–Induced Immune ResponsesScience, 2009
- Screening for tuberculosis infection prior to initiation of anti-TNF therapyAutoimmunity Reviews, 2008
- Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial triggerProceedings of the National Academy of Sciences of the United States of America, 2008
- Type I interferon–inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositisArthritis & Rheumatism, 2007
- Small self-RNA generated by RNase L amplifies antiviral innate immunityNature, 2007
- The role of disease stage, plasma viral load and regulatory T cells (Tregs) on autoantibody production in SIV-infected non-human primatesJournal of Autoimmunity, 2007
- Toll-like receptors in systemic autoimmune diseaseNature Reviews Immunology, 2006
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and MalignanciesJAMA, 2006
- Initial sequencing and analysis of the human genomeNature, 2001